By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Proteo Biotech AG 

Am Kiel-Kanal 44

Kiel    D-24106  Germany
Phone: 49-431-8888-462 Fax: 49-431-8888-463


SEARCH JOBS


Industry
Biotechnology






Company News
Proteo Inc. (PTEO.OB) / Proteo Biotech AG (PTEO.OB): Patient Recruitment and Treatment in Elafin CABG Phase II Clinical Trial Completed 11/8/2013 8:09:01 AM
Proteo Inc. (PTEO.OB) /Proteo Biotech AG (PTEO.OB): FDA Grants Orphan Drug Designation to Elafin for Prevention of Inflammatory Complications of Transthoracic Esophagectomy 3/21/2013 11:27:19 AM
Proteo Inc. (PTEO.OB)/ Proteo Biotech AG (PTEO.OB): Proteo's Elafin Will Be Tested at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) 6/18/2010 6:22:05 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Successful Completion of Patient Recruitment for the Phase II Clinical Trial on Elafin in Patients with Esophagus Cancer 4/23/2010 10:03:28 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): European Medicines Agency European Medicines Evaluation Agency Recommends Orphan Drug Status for Elafin in the Treatment of Esophagus Carcinoma 11/16/2009 10:16:17 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB) - Minapharm/Rhein Minapharm Biogenetics SAE: Approval for a Phase II Clinical Trial with Elafin in Kidney Transplantation 12/10/2008 10:04:58 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Start of the Phase II Clinical Trial With Elafin 11/17/2008 11:36:42 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB) - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech AG (PTEO.OB), Germany and Minapharm, Egypt Enter into Development and License Agreement for Elafin 8/9/2007 1:28:30 PM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): European Commission grants Orphan Drug Status to Elafin for the treatment of PAH 3/29/2007 12:30:26 PM
Proteo Biotech AG (PTEO.OB): New Member Of Advisory Board Will Strengthen Company Development 5/18/2006 6:40:01 PM
12
//-->